“Autoimmune haemolytic anaemia”的搜索结果，显示 311-320 项，共有 9460 项

1. 血液科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

2. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...

3. 血液科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz., Rochester, Minn. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

4. 神经系统副肿瘤综合征- 症状与病因- 妙佑医疗国际

   AskMayoExpert. Autoimmune and paraneoplastic neurologic syndromes (adult). Mayo Clinic; 2020. Dalmau J, et al. Paraneoplastic syndromes affecting the spinal ...

5. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

6. 自身免疫性脑炎- 医生与科室- 妙佑医疗国际

   rotein antibody-associated disease, Transverse myelitis, Autoimmune encephalitis, Autoimmune epilepsy, Paraneoplastic syndromes of the nervous system.

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

8. 血液科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. This phase II trials studies how well acalabrutinib with or without obinutuzumab works in ...

9. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...